Over the past few decades, a surge in the use of plastics due to increase in consumer demand for safety and convenience in packaged food and beverages has been observed. When it comes to food and beverages packaging, terms such as ’green’, ’organic’, ‘fair trade’, and ’locally sourced’ have been drawing the attention of consumers in the recent years. With climatic changes taking place, health awareness, and environmental issues are growing. Furthermore, media coverage has made consumers more aware about the factors that are guiding their purchasing decisions, which has been driving the growth in the bioplastics packaging market.

Request For Sample Report : http://www.mrrse.com/sample/427

Bioplastics packaging covers an array of industries, including organic foods, fruits and vegetables, beverages, bread and bakery products, and catering, which require disposable utensils (cups, mugs, trays, plates, and cutlery).

Bioplastics have been gaining attention of policymakers in the packaging domain in recent years as it is being sourced from renewable resources and carry implications for sustainable development. Governments in several countries are against the compost of non-biodegradable conventional plastics for land filling and have been formulating several laws and policies that limit their use. Excessive use of conventional plastics has led to an increase in carbon dioxide emission, toxic landfills, and polluted water, which is affecting public health and soil fertility. As a result, policymakers have been encouraging production and use of bioplastics. The U.S. government introduced the Title IX, the energy title of the 2008 farm bill (P.L. 110-240), which encourages federal agencies to buy bioplastics items including bioplastics packaging products.

The increasing demand for bioplastics packaging for food and beverages is the result of certain advantages that bioplastics have over conventional plastics such as glossy and attractive appearance, antistatic behavior, printability, barrier effect, and enhanced shelf life of fresh products. Ongoing technology advancements for improvement of physical properties of bioplastics is another major driver of the bioplastics packaging market for food and beverages industry.

The impact of increasing crude oil prices and declining oil resources is also expected to increase in the longer run, thus encouraging the growth of bioplastics packaging market. The large economies of the world have been heavily investing to reform their energy infrastructure and thus, this factor is expected to have high impact as a growth driver in the long term for global bioplastics packaging market for food and beverages industry.

The introduction of nanotechnology-based bioplastics for food and beverages packaging has opened many new application in food and beverages packaging for bioplastics over the years. Nano-enabled packaging ensures food product safety, environmental safety, and improved performance characteristics such as barrier properties particularly in PLA and starch based bioplastics which makes them suitable for many moisture content foods packaging application.

Browse Full Report With TOC:  http://www.mrrse.com/bioplastic-packaging-market

Complex separation of bioplastics from the disposal site based on their resin type makes the recycling process tough, which is one of the restraints for the growth of this bioplastics packaging market for food and beverages. The market of bioplastics packaging in food and beverages industry is consolidated with fewer companies accounting for larger portion of the market. Some favorable legislative reforms and new product development holds large opportunities for the bioplastics packaging market.

Key points covered in the report

The report provides historic, present and forecasted market size, analysis, trend, share, and growth
The report segments the market on the basis of product, application and geography
The report covers geographic segmentation
North America
Europe
Asia Pacific
Rest of the World (RoW)
The report provides company profiles of some of the leading companies operating in the market
The report also provides porters five forces analysis of the market
This report on thin film drug manufacturing market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of thin film drug manufacturing products such as oral thin film, transdermal thin film and others as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global thin film drug manufacturing market with respect to the leading market segments based on major disease indication segment, products segment, distribution channels, and geographies.

Request For Sample Report : http://www.mrrse.com/sample/3088

Global Thin Film Drug Manufacturing Market: Segmentation

Based on the product type, the thin film drug manufacturing market has been segmented into: oral thin film, transdermal thin film and others. Each of the market segments have been extensively analyzed based on the market related factors such as increasing demand of thin film drug manufacturing products worldwide, and technological advancement. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

Global Thin Film Drug Manufacturing Market: Drivers and Trends

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the thin film drug manufacturing market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global thin film drug manufacturing market.

Global Thin Film Drug Manufacturing Market: Regional Outlook

Geographically, thin film drug manufacturing market has been segmented into five major regions: North America, Europe, Asia, Latin America, and Middle East and Africa. The market size and forecast for each of these regions has been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global thin film drug manufacturing market.

Key Players Mentioned in this Report are:

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global thin film drug manufacturing market. The report also profiles key players operating in the thin film drug manufacturing market which are Pfizer, Inc., Novartis AG, Allergan plc, Wolters Kluwer, Solvay, IntelGenx Corp., Sumitomo Dainippon Pharma Co., Ltd., Indivior plc and ZIM Laboratories Limited

Browser Full Report With TOC : http://www.mrrse.com/thin-film-drug-manufacturing-market

The global thin film drug manufacturing market is segmented as follows:

Global Thin Film Drug Manufacturing Market, by Product Type
About Us

Market Research Reports Search Engine(MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY - 12207
United States
Telephone: +1-518-730-0559
Email: [email protected]
Google+: https://plus.google.com/u/0/109558601025749677847/posts
Linked in: https://www.linkedin.com/company/mrrse
Twitter: https://twitter.com/MRRSEmrrse